FDA Approves Amphastar Pharma's Nasal Spray for Opioid Overdose

Argentina Noticias Noticias

FDA Approves Amphastar Pharma's Nasal Spray for Opioid Overdose
Argentina Últimas Noticias,Argentina Titulares
  • 📰 Medscape
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 55%

Amphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.

- Amphastar Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration had approved its nasal spray for emergency treatment of known or suspected opioid overdose.

The company's naloxone hydrochloride nasal spray can be delivered in one spray by intranasal administration — delivering 4 mg of the drug in adults and pediatric patients — for an initial dosing, according to the FDA label. The regulator's approval allows its use only when prescribed. The nod comes at a time when the agency is reviewing applications to also allow over-the-counter use of some naloxone-based drugs, including an application for Emergent Biosolutions' Narcan.

Late last year, the health regulator had said naloxone might be safe and effective for over-the-counter use in some forms, potentially paving the way for its use federally and encouraging more manufacturers to seek approval for prescription-free use. More than 106,000 people died in the U.S. from drug-involved overdose in 2021, according to government data.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Medscape /  🏆 386. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

WSJ News Exclusive | New Drugs Are Coming to Market at Sky-High PricesWSJ News Exclusive | New Drugs Are Coming to Market at Sky-High PricesDrugmakers are launching brand-name medicines with ever-higher price tags on day one. New drugs for cancer and rare diseases can cost more than $20,000 a month.
Leer más »

Albuterol Shortage Challenges Hospitals Treating Patients With Breathing ProblemsAlbuterol Shortage Challenges Hospitals Treating Patients With Breathing ProblemsHospitals are running out of a liquid form of albuterol, a medication used to treat people with breathing problems, weeks after the only maker of the product declared bankruptcy
Leer más »

Holding the FDA accountable: How chemical abortion harms AmericansHolding the FDA accountable: How chemical abortion harms Americans[This is part one of a series on the first-of-its-kind federal lawsuit, Americans for Hippocratic Medicine v. U.S. Food and Drug Administration, in which doctors and medical practitioners are asking the courts to hold the FDA accountable for its reckless and illegal approval of dangerous chemical…
Leer más »

Jenna Ortega Changed ‘Wednesday’ Scenes That “Did Not Make Sense”Jenna Ortega Changed ‘Wednesday’ Scenes That “Did Not Make Sense”“I don’t think I’ve ever had to put my foot down on a set in a way that I had to on ‘Wednesday,’” she said in a recent podcast interview.
Leer más »

Senate vote on overturning D.C. criminal code bill expected WednesdaySenate vote on overturning D.C. criminal code bill expected WednesdayDemonstrators protesting congressional interference in D.C. affairs plan to gather outside Union Station before marching to First Street and Constitution Avenue for a rally.
Leer más »

BoJ announces bond-buying operation on WednesdayBoJ announces bond-buying operation on WednesdayThe Bank of Japan (BoJ) announced that it conducted bond-buying in its routine daily operation on Wednesday. Key details “BoJ Offers To Buy JPY1.90Tln
Leer más »



Render Time: 2025-04-20 18:51:20